Dual Contraceptive Use and Factor Associated with People Living with HIV/AIDS: A Systematic Review and Meta-Analysis.
| Autor: | Mesfin Y; Department of Midwifery, College of Medicine and Health Science, Wolkite University, Wolkite, Ethiopia., Argaw M; Department of Midwifery, College of Medicine and Health Science, Wolkite University, Wolkite, Ethiopia., Geze S; Department of Midwifery, College of Medicine and Health Science, Wolkite University, Wolkite, Ethiopia., Tefera B; Department of Nursing, College of Medicine and Health Science, Wolkite University, Wolkite, Ethiopia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Infectious diseases in obstetrics and gynecology [Infect Dis Obstet Gynecol] 2021 Aug 16; Vol. 2021, pp. 5440722. Date of Electronic Publication: 2021 Aug 16 (Print Publication: 2021). |
| DOI: | 10.1155/2021/5440722 |
| Abstrakt: | Introduction: A dual contraceptive method is the usage of any modern contraceptive method with male or female condoms which could lower sexually transmitted diseases and unwanted pregnancy. Ethiopian standard utilization of dual contraceptive is low. The hassle is more severe for HIV/AIDS-infected people. Therefore, this review was aimed at assessing dual contraceptive utilization and factor associated with people living with HIV/AIDS in Ethiopia. Method: International databases (PubMed/MEDLINE, Hinari, Embase, African Journals Online, Scopus, and Google Scholar) and Ethiopian university repository online have been covered in this review. Microsoft Excel was used for extraction, and the Stata 14 software program was used for analysis. We detected the heterogeneity between studies using the Cochran Q statistic and I 2 test. Publication bias was assessed by funnel plot and Egger's and Begg's tests. Result: The overall prevalence of dual contraceptive use among people living with HIV/AIDS was 27.73% (95% CI: 20.26-35.19) in Ethiopia. Discussion with the partner (OR: 3.78, 95% CI: 3.08-4.69), HIV status disclosure to the spouse/partner (OR: 2.810, 95% CI: 2.26-3.48), postdiagnosis counseling (OR: 5.00, 95% CI: 3.71-6.75), schooling in secondary and above education (OR: 3.78, 95% CI: 2.41-5.93), partner involvement in counseling (OR: 2.76, 95% CI: 1.99-3.82), urban residence (OR: 2.84, 95% CI 2.03-3.94), and having no fertility desire (OR: 4.01, 95% CI 2.91-5.57) were significantly associated with dual contraceptive use. Conclusion: Dual contraceptive utilization among people living with HIV/AIDS was found to be low in Ethiopia. This will be a significant concern unless future intervention focuses on rural residence, involvement of the partner in postdiagnosis counseling, encouraging the people living with HIV/AIDS to disclose HIV status, and discussion with the partner. Providing counseling during the antenatal and postnatal period also enhances dual contraceptive use. Competing Interests: The authors declare that there is no financial and nonfinancial conflict of interest regarding the publication of this paper. (Copyright © 2021 Yibeltal Mesfin et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|